http://purl.org/np/RA7EdbfyCP... RA7EdbfyCP

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-08-16T14:12:57.108Z

http://purl.org/np/RA7EdbfyCP... RA7EdbfyCP

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/DRUGBANK:DB00934 DRUGBANK:DB00934

0000-0002-7641-6446

2021-08-16T14:12:57.108Z

http://purl.org/np/RA7EdbfyCP... RA7EdbfyCP

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-08-16T14:12:57.108Z

http://purl.org/np/RA7EdbfyCP... RA7EdbfyCP

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-08-16T14:12:57.108Z

http://purl.org/np/RA7EdbfyCP... RA7EdbfyCP

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0005546 MONDO_0005546

0000-0002-7641-6446

2021-08-16T14:12:57.108Z

http://purl.org/np/RA7EdbfyCP... RA7EdbfyCP

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-08-16T14:12:57.108Z

http://purl.org/np/RA7EdbfyCP... RA7EdbfyCP

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/31821138 pubmed.ncbi.nlm.nih.gov/31821138

0000-0002-7641-6446

2021-08-16T14:12:57.108Z

http://purl.org/np/RA7EdbfyCP... RA7EdbfyCP

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

TCAs can serve as first-line or augmenting drugs for neuropathic pain, headache, migraine, gastrointestinal syndromes, fibromyalgia, pelvic pain, insomnia, and psychiatric conditions other than depression.

0000-0002-7641-6446

2021-08-16T14:12:57.108Z